Inhalers and nebulizers play a key role in delivering medication to the lungs, making it easier for people with breathing ...

Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Israel-based Teva said the system conveys information to patients, who can use the product ... pulmonary disease (COPD). Teva noted it is the first and only digital rescue inhaler indicated ...

Fluticasone is a prescription corticosteroid for long-term treatment of respiratory disorders, such as asthma and COPD. It is not supposed to relieve sudden breathing problems, so it won’t replace a ...

Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...

The cold, dry air, reduced sunlight, and increased risks of respiratory infections combine to exacerbate symptoms for ...

[26] These cost and reimbursement factors may affect patient adherence to therapy and thus warrant early consideration in elderly patients with COPD.

PORTLAND, OR, UNITED STATES, December 9, 2024 /EINPresswire / -- The global pulmonary drug delivery systems market is experiencing significant growth, driven by various factors including the rising ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...